Skip to main content
. 2019 Apr 28;2019:5793867. doi: 10.1155/2019/5793867

Figure 4.

Figure 4

Pooled estimates of infarct size for resveratrol vs. vehicle ex vivo. Resveratrol treatment reduced the infarct size in ex vivo studies (WMD: -15.05, 95% CI: -18.23 to -11.86, P ≤ 0.001). Gray squares represent WMDs in studies. The 95% CIs for each studies are denoted by lines and those for the pooled WMDs by open diamonds. Meta-analysis is performed by the random effects model.